Intermountain Healthcare Researchers Develop New Diagnostic Tool to Identify & Treat COVID-19 Patients at Risk of Severe Illness, Death Due to Inflammatory Disorder
Retrieved on:
Thursday, October 1, 2020
With the new scoring diagnostic criteria, clinicians can now identify patients early and ideally prescribe treatments before the condition progresses and causes patients to deteriorate to critical levels.
Key Points:
- With the new scoring diagnostic criteria, clinicians can now identify patients early and ideally prescribe treatments before the condition progresses and causes patients to deteriorate to critical levels.
- For the study, researchers applied the new cHIS diagnostic score to 299 patients admitted to Intermountain hospitals with severe COVID-19.
- Intermountain Healthcare is a not-for-profit system of hospitals and clinics, a Medical Group, health insurance, and other health services in Idaho, Utah, and Nevada.
- Intermountain is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes and sustainable costs.